The study and its comparison
The six-month BENEFIC report assessed cognition in 39 people receiving a medium-chain-triglyceride drink and 44 receiving placebo. Participants had mild cognitive impairment; the drink supplied fifteen grams of MCT twice daily. [1]
Selected measures of recall, verbal fluency, naming and trail-making errors improved relative to placebo after statistical adjustment. Some cognitive results also correlated with circulating ketones. [1]
What the finding establishes
A correlation does not establish that ketones caused the cognitive change. The study did not establish prevention of Alzheimer’s disease, and MCT is not the same intervention as a beta-hydroxybutyrate salt. Authors disclosed industry relationships, including Nestle employment and consulting or product support. Complete funding was not established from the abstract. The assessed groups should not be mistaken for a confirmed original enrollment count. [1]
A hypothetical distinction
Imagine a naming score improves after six months. Progression to dementia still needs a separate, longer clinical assessment.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.